Skip to main content

Month: February 2021

Tillful.com Reveals Monitoring Your Business Credit Score

Your business credit score is one of your company’s most important assets. Like any other asset, it is important to safeguard and manage it. The accuracy of the data being presented about your business will influence how other entities view your business. This means that every business needs to monitor their credit score regularly. Your company’s credit score does not remain stagnant. Payment activity, outstanding balances, and other financial transactions alter your company’s credit score as they happen. This means your credit profile continues changing based on the nature of these transactions. Monitoring your credit report allows you to ensure that the data about your business is accurate and up to date.As a business, there are five key reasons to monitor your credit score. Credit Score Management A good credit score can mean access...

Continue reading

Mojave Announces Stock Option Grant

VANCOUVER, British Columbia, Feb. 18, 2021 (GLOBE NEWSWIRE) — MOJAVE GOLD CORP. (TSXV:MOJ) (OTCBB:MOJGF) (“Mojave” or the “Company”) is pleased to announce that all required filings have been filed. As a result of the management cease trade order (the “MCTO”) that was granted by British Columbia Securities Commission on December 30, 2020, the MCTO has been lifted.The Company also wishes to announce that it has entered into stock option agreements granting the right and option to purchase 2,700,000 common shares of the Company at $0.42 per common share exercisable in whole or in part on or before five years from February 18, 2026.On behalf of the Board of Directors“Greg Bronson”President / CEOMojave Gold Corp.For more information contact Greg Bronson, Presidentinfo@Mojavegoldcorp.comForward Looking StatementsCertain of the statements...

Continue reading

RECORD RESULTS FOR PROFIT AND CASH FLOW – SIKA STRONG IN YEAR OF CORONAVIRUS

RECORD RESULTS FOR PROFIT AND CASH FLOW – SIKA STRONG IN YEAR OF CORONAVIRUSSales of CHF 7,877.5 million (-2.9% in CHF, +3.4% in local currencies)EBITDA increased to CHF 1,497.6 million (+7.9%)Operating profit (EBIT) increased to CHF 1,130.5 million (+7.1%)EBIT margin increased to 14.4% (previous year: 13.0%)Net profit up to CHF 825.1 million (+8.8%)Operating free cash flow increased to CHF 1,259.4 million (+22.7%)Reduction of CO2 emissions by 25.9% to 20 kg per ton sold (previous year: 27 kg per ton sold)6 factories opened or extended, 1 company acquired and one expanded partnershipProposal for dividend increase of 8.7% to CHF 2.50 (previous year: CHF 2.30)From May 1, 2021: Thomas Hasler to succeed CEO Paul SchulerOutlook for 2021 fiscal yearSales increase in local currencies of 6%–8%Over-proportional increase in EBIT, EBIT margin to...

Continue reading

REKORDERGEBNISSE BEI GEWINN UND GELDFLUSS – SIKA STARK IM CORONA-JAHR

REKORDERGEBNISSE BEI GEWINN UND GELDFLUSS – SIKA STARK IM CORONA-JAHRUmsatz von CHF 7’877.5 Millionen (-2.9% in CHF, +3.4% in Lokalwährungen)EBITDA auf CHF 1’497.6 Millionen gesteigert (+7.9%)Betriebsgewinn auf CHF 1’130.5 Millionen gesteigert (+7.1%)EBIT-Marge erhöht auf 14.4% (Vorjahr: 13.0%)Reingewinn auf CHF 825.1 Millionen ausgebaut (+8.8%)Operativer Freier Geldfluss auf CHF 1’259.4 Millionen gesteigert (+22.7%)Reduktion des CO2-Ausstosses um 25.9% auf 20 kg pro verkaufter Tonne (Vorjahr: 27 kg pro verkaufter Tonne)Eröffnung oder Erweiterung von 6 Fabriken sowie 1 Akquisition und eine erweiterte PartnerschaftAntrag auf Dividendenerhöhung um 8.7% auf CHF 2.50 (Vorjahr: CHF 2.30)Ab 1. Mai 2021: Thomas Hasler Nachfolger von CEO Paul SchulerOutlook Geschäftsjahr 2021Umsatzsteigerung in Lokalwährungen von 6%–8%überproportionale...

Continue reading

ClearPoint Neuro Announces Pricing of Public Offering of 1,850,140 Shares of Common Stock

IRVINE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today the pricing of its underwritten public offering of 1,850,140 shares of its common stock at a price to the public of $23.50 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 277,520 shares of its common stock at the public offering price less underwriting discounts and commissions. All the shares are being offered by the Company. The offering is expected to close on February 23, 2021, subject to customary closing conditions.The Company intends to use the net proceeds from this offering to fund product development and research and development activities and the...

Continue reading

ThreeD Capital Inc. Announces Extension of Warrant Terms

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S.TORONTO, Feb. 18, 2021 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (the “Company” or “ThreeD”) (CSE:IDK) (OTCQB:IDKFF) announces that it is extending the term of certain of its existing share purchase warrants of the Company, as follows (collectively, the “Warrants”):Each Warrant is currently exercisable at $1.80, which will remain unchanged. The extension of the respective expiry dates of the Warrants has been approved by the board of directors of the Company.About ThreeD Capital Inc.ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors.  ThreeD’s investment strategy is to invest in multiple private and public companies across a variety...

Continue reading

Junshi Biosciences Announces Acceptance by the NMPA of Supplemental New Drug Application for Toripalimab Combined with Chemotherapy for The First-Line Treatment of Nasopharyngeal Carcinoma

SHANGHAI, China, Feb. 19, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the National Medical Products Administration (NMPA) of China has accepted its supplemental New Drug Application (sNDA) for Toripalimab combined with chemotherapy for the first-line treatment of patients with recurrent or metastatic nasopharyngeal carcinoma.The supplemental NDA is based on the JUPITER-02 study (NCT03581786), which is a randomized, double-blind, placebo-controlled Phase III study led by Professor Ruihua Xu from Sun Yat-sen University Cancer Center. The results of the study showed that Toripalimab combined with gemcitabine/cisplatin as a first-line treatment for patients...

Continue reading

Updated: International Land Alliance Announces Sales and Marketing Collaboration with Baja 123 Real Estate

SAN DIEGO, CALIFORNIA, Feb. 18, 2021 (GLOBE NEWSWIRE) — International Land Alliance, Inc. (OTCQB: ILAL) announced today a sales and marketing collaboration with Baja 123 Real Estate (www.baja123.com) for its Plaza Bajamar development.Founded in 2005, Baja 123 is a high-tech real estate company based in Rosarito Beach, Baja California and the first office in Northern Baja California under the eXp Mexico banner. Grupo eXp Realtors Mexico is affiliated with eXp Realty, LLC, one of the fastest-growing real estate companies in the world. eXp announced its expansion into Mexico in December 2020. In addition to its U.S. and Mexico presence, eXp Realty operates in seven other countries, including Australia, Canada, France, India, Portugal, South Africa and the United Kingdom, with more than 43,000 agents across the globe.Roberto Valdes,...

Continue reading

Tailwind International Acquisition Corp. Announces Pricing of Upsized $300 Million Initial Public Offering

NEW YORK, Feb. 18, 2021 (GLOBE NEWSWIRE) — Tailwind International Acquisition Corp. (the “Company”), a special purpose acquisition company formed for the purpose of entering into a business combination with one or more businesses, today announced the pricing of its upsized initial public offering of 30,000,000 units at a price of $10.00 per unit on February 18, 2021. The units will be listed on the New York Stock Exchange and trade under the ticker symbol “TWNI.U” beginning on February 19, 2021. Each unit consists of one Class A ordinary share of the Company and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share of the Company at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants...

Continue reading

Teladoc Health is Providing Free Virtual Health Care Services to those Impacted by Winter Storms in Oklahoma and Texas

PURCHASE, NY, Feb. 18, 2021 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, is providing free, 24/7 general medical telehealth visits to Oklahoma and Texas residents, first responders and others directly impacted by winter storms. Individuals who have been displaced or cannot access medical care as a result of the winter weather can seek treatment from a board-certified, state licensed physician for any non-emergency illness by calling Teladoc directly at 855-225-5032.“Communities in Oklahoma and Texas are simultaneously challenged by widespread electricity and heat loss due to winter storms and an active pandemic. By enabling greater access to virtual care, we can help keep the health of those in need front and center,” said Dr. Lewis Levy, FACP, chief medical officer, medical...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.